BNP Paribas Financial Markets’s VanEck Pharmaceutical ETF PPH Stock Holding History

BNP Paribas Financial Markets’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$57M	Buy	549,000 +249,000	+83%	+$26.5M	0.03%	617
2025 Q4	$31M	Buy	300,000 +191,371	+176%	+$18.6M	0.01%	932
2025 Q3	$9.82M	Hold	108,629	–	–	0.01%	1550
2025 Q2	$9.56M	Hold	108,629	–	–	0.01%	1476
2025 Q1	$9.9M	Buy	108,629 +49,996	+85%	+$4.5M	0.01%	1413
2024 Q4	$5.06M	Buy	+58,633	New	+$5.3M	﹤0.01%	1765
2024 Q3	–	Sell	-1,800	Closed	-$165K	–	4216
2024 Q2	$165K	Sell	1,800 -6	-0.3%	-$536	﹤0.01%	3160
2024 Q1	$164K	Sell	1,806 -99,998	-98%	-$8.76M	﹤0.01%	3302
2023 Q4	$8.28M	Sell	101,804 -150,004	-60%	-$11.8M	0.01%	1116
2023 Q3	$20.1M	Sell	251,808 -148,992	-37%	-$12M	0.03%	608
2023 Q2	$31.6M	Buy	400,800 +300,300	+299%	+$23.5M	0.04%	434
2023 Q1	$7.8M	Hold	100,500	–	–	0.01%	1022
2022 Q4	$7.81M	Hold	100,500	–	–	0.01%	1087
2022 Q3	$6.76M	Buy	100,500 +50,500	+101%	+$3.72M	0.01%	1205
2022 Q2	$3.84M	Buy	+50,000	New	+$3.9M	0.01%	1364
2021 Q2	–	Sell	-200,000	Closed	-$13.8M	–	4095
2021 Q1	$13.8M	Buy	+200,000	New	+$13.8M	0.02%	678
2020 Q2	–	Sell	-100,406	Closed	-$5.46M	–	4371
2020 Q1	$5.46M	Sell	100,406 -904,000	-90%	-$55.7M	0.01%	941
2019 Q4	$64.5M	Buy	1,004,406 +604,406	+151%	+$36.4M	0.12%	176
2019 Q3	$22.8M	Buy	+400,000	New	+$22.9M	0.04%	450

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets's PPH Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its VanEck Pharmaceutical ETF (PPH) stake by 83% in Q1 2026, buying an estimated $26.5M and bringing the position to 549,000 shares worth $57M. The position accounts for 0.03% of the portfolio, ranked #617.

BNP Paribas Financial Markets first reported a position in PPH in Q3 2019 and has held it in 19 quarters since. The position peaked at $64.5M in Q4 2019. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

BNP Paribas Financial Markets held 549,000 shares of VanEck Pharmaceutical ETF worth $57M as of Q1 2026.
BNP Paribas Financial Markets bought 249,000 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $26.5M.
VanEck Pharmaceutical ETF made up 0.03% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #617 holding.
BNP Paribas Financial Markets first reported a position in VanEck Pharmaceutical ETF in Q3 2019 and has held it in 19 quarters since.
BNP Paribas Financial Markets's VanEck Pharmaceutical ETF position peaked at $64.5M in Q4 2019.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.